BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-965@pharmaconomics
DTSTAMP:20260707T021634Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:STOK PDUFA — zorevunersen (estimated date)
DESCRIPTION:The FDA's approval decision on zorevunersen for Dravet syndrome is due ~ Jun 30\, 2027. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1623526/000119312526009781/d36198d8k.htm\n\nTrack it: https://pharmaconomics.com/e/965
URL:https://pharmaconomics.com/e/965
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:STOK catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR